Fig. 1

Validation and comparison of the AFP, Metroticket 2.0, and Up-to-7 models in the present HCC LT cohort. The cumulative incidence of recurrence in the present HCC LT cohort grouped by the AFP (A), Metroticket 2.0 (B), and Up-to-7 (C) models. Comparison of the 3 models was performed using AUC analysis and is expressed with c-statistics and 95% CI (D). *P < 0.05. The time-dependent receiver operating characteristic curve (ROC) value for different models according to tumor recurrence (E)